Jenny Chang

Jenny Chang

Auto-generated profile, based on publicly available information

Jenny Chang

Department of Medicine, School of Medicine, University of California, 205 Irvine Hall, Irvine, CA, 92697, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Hannah Lui ParkHannah Lui Park
Hannah Lui Park
AZArgyrios Ziogas
Argyrios Ziogas
JCJenny Chang
Jenny Chang
BDBhumi Desai
Bhumi Desai
LBLeona Bessonova
Leona Bessonova
HAHoda Anton-Culver
Hoda Anton-Culver
The ability of tamoxifen and raloxifene to decrease breast cancer risk varies among different breast cancer subtypes. It is important to determine one’s subtype-specific breast cancer risk when considering chemoprevention. A number of single nucleotide polymorphisms (SNPs), including one in caspase-8 (CASP8), have been previously associated with risk of developing breast cancer. Because caspase-8 is an important protein involved in receptor-mediated apoptosis whose activity is affected by estrogen, we hypothesized that additional SNPs in CASP8 could be associated with breast cancer risk, perhaps in a subtype-specific manner. Twelve tagging SNPs of CASP8 were analyzed in a nested case control study (1,353 cases and 1,384 controls) of non-Hispanic white women participating in the California Teachers Study. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated for each SNP using all, estrogen receptor (ER)-positive, ER-negative, human epidermal growth factor receptor 2 (HER2)-positive, and HER2-negative breast cancers as separate outcomes. Several SNPs were associated with all, ER-positive, and HER2-positive breast cancers; however, after correcting for multiple comparisons (i.e., p < 0.0008), only rs2293554 was statistically significantly associated with HER2-positive breast cancer (OR = 1.98, 95 % CI 1.34-2.92, uncorrected p = 0.0005). While our results for CASP8 SNPs should be validated in other cohorts with subtype-specific information, we conclude that some SNPs in CASP8 are associated with subtype-specific breast cancer risk. This study contributes to our understanding of CASP8 SNPs and breast cancer risk by subtype.

3 October 2020 in Cancer Epidemiology
Verified
Journal Article
Closed access
CVCarolina Villanueva
Carolina Villanueva
JCJenny Chang
Jenny Chang
AZArgyrios Ziogas
Argyrios Ziogas
RBRobert E. Bristow
Robert E. Bristow
VVVeronica Vieira
Veronica Vieira